Purpose: Electromagnetic tracking (EMT) is a promising technology for automated catheter and applicator reconstructions in brachytherapy. In this work, a proof-of-concept is presented for reconstruction of the individual channels of a new shielded tandem (140 mm long shield) dedicated to intensity-modulated brachytherapy.
Methods: All six channels of a straight prototype were reconstructed using an electromagnetic (EM) system from Aurora (NDI, Waterloo, ON, Canada). The influence of the shield on the EMT system was characterized by taking measurements at nine different positions with and without the shielded part of the applicator next to the probe. A Student t-test was used to analyze the data.
Results: For registration purposes, the center-to-center distance (4 mm) was taken from the computed-assisted design (CAD) structure. The computed interchannel distances from the three opposite pairs were 4.33 ± 0.40 mm, 4.14 ± 0.35 mm, and 3.88 ± 0.26 mm. All interchannel distances were within the geometrical tolerance in the shielded portion of the applicator (±0.6 mm) and account for the fact that the sensor (0.8 mm diameter) was smaller than the channel diameter. According to the paired Student t-test, the data given by the EM system with and without the shielded applicator tip are not significantly different.
Conclusion: This study shows that the reconstruction of channel path is possible within the mechanical accuracy of the applicator.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mp.12789 | DOI Listing |
Brachytherapy
November 2024
Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA.
Purpose: Suture preplacement by the ocular oncology surgeon is a critical step before inserting a radioactive plaque for ocular melanoma brachytherapy. We report on a novel 3D-printing method to create a custom "dummy" plaque applicator for the 22 mm notched gold plaque using in-house 3D-printing.
Methods: A computer-aided design (CAD) file was created replicating a heavily used gold plaque that no longer has a satisfactory "dummy" plaque.
Cancers (Basel)
October 2024
Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA.
Brachytherapy offers a highly conformal and adaptive approach to radiation therapy for various oncologic conditions. This review explores the rationale, applications, technological advances, and future directions of personalized brachytherapy. Integration of advanced imaging techniques, 3D-printed applicators, and artificial intelligence are rapidly enhancing brachytherapy delivery and efficiency, while genomic tests and molecular biomarkers are refining patient and dose selection.
View Article and Find Full Text PDFJ Appl Clin Med Phys
October 2024
Department of Physics and Atmospheric Science, Dalhousie University, Halifax, Canada.
Phys Med Biol
October 2024
Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia, United States of America.
With advancements in high-dose rate brachytherapy, the clinical translation of intensity modulated brachytherapy (IMBT) innovations necessitates utilization of model-based dose calculation algorithms (MBDCA) for accurate and rapid dose calculations. This study uniquely benchmarks a commercial MBDCA, BrachyVision ACUROS(BVA), against Monte Carlo (MC) simulations, evaluating dose distributions for a novel IMBT applicator, termed as theDirection Modulated Brachytherapy (DMBT) tandem, expanding beyond previous focus on partially shielded vaginal cylinder applicators, through a novel methodology.The DMBT tandem applicator, made of a tungsten alloy with six evenly spaced grooves, was simulated using the GEANT4 MC code.
View Article and Find Full Text PDFDiscov Oncol
September 2024
Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Introduction: The utilization of metal shields in intensity-modulated brachytherapy (IMBT) enables the modulation of the dose, resulting in improved conformance to the tumor while simultaneously reducing the doses to organs at risk (OARs). Utilizing higher-energy sources like Co in IMBT for cervical and vaginal cancers has consistently posed challenges. This study evaluates the dosimetric aspects of modified applicators designed for IMBT using Co and Ir sources.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!